Work

A Phase 2 Study to Evaluate Overall Response Rates in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine with or without Deferasirox

Year: 2015

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.07.098

Authors: Vu H. Duong, Vinod Pullarkat, Katie McNamara, Jason Esposito, Brian Elliott, Pradyumna Phatak

Institutions: University of Maryland Medical Center, City Of Hope National Medical Center, Rochester General Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2200369048

FWCI:

Cites:

Cited by:

Related to: 10